- Home
- PLBY vs MIST Comparison
PLBY vs MIST Comparison
Compare PLBY & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLBY | MIST |
|---|---|---|
| Founded | 1953 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.5M | 176.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLBY | MIST |
|---|---|---|
| Price | $1.80 | $2.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.00 | ★ $8.00 |
| AVG Volume (30 Days) | 749.7K | ★ 3.2M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,928,000.00 | N/A |
| Revenue This Year | $9.17 | $2,915.14 |
| Revenue Next Year | $7.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $0.93 | $0.98 |
| 52 Week High | $2.75 | $3.06 |
Technical Indicators
Market Signals| Indicator | PLBY | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 64.79 |
| Support Level | $1.65 | $1.84 |
| Resistance Level | $1.99 | $2.28 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 81.91 | 79.38 |
Price Performance
Historical ComparisonAbout PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).